🤑 It doesn’t get more affordable. Grab this 60% OFF Black Friday offer before it disappears…CLAIM SALE

Investors urged to focus on late-cycle stock sectors amid economic uncertainty

Published 19/09/2023, 03:28
© Reuters.
US2000
-
ACN
-
BSX
-
AZO
-
CL
-
BMRN
-

Amid economic uncertainty in the United States, Mike Wilson, Morgan Stanley's top U.S. equity strategist, has advised investors on Monday to focus on late-cycle stock sectors. This advice comes as part of a balanced portfolio approach that involves a combination of defensive growth sectors and late-cycle cyclicals.

Wilson's strategy suggests that investors should maintain a balanced portfolio until more concrete economic data is available. The approach includes sectors such as healthcare and consumer staples, known for their defensive growth, coupled with late-cycle cyclicals like industrials and energy. Despite the underperformance of these sectors this year, Wilson emphasizes that it's premature to shift investments towards small and mid-cap stocks. This is evident from the mere 4% rise in the Russell 2000 RUT in 2023.

The energy sector has become an area of interest for investors due to rising crude oil prices, which recently neared $92 per barrel. Wilson identifies this sector as a frequent late-cycle performer, often driven by the strength of commodities. Factors such as robust oil demand, significant production reductions, and steady crude prices are seen as enhancing the sector's performance.

This appeal of the energy sector is further underscored by its recovery from a period of underperformance that lasted from November of the previous year to July of this year. Currently, the sector offers attractive valuations and increased earnings revisions. It also generates substantial free cash flow and has the ability to repay debt if necessary. This resurgence occurs at a time when hedge fund exposure to the energy sector is unusually low.

Wilson highlighted several defensive growth stocks that have outperformed both annually and more recently. These stocks include NYSE:ACN Accenture (NYSE:ACN), NASDAQ:AAPL Apple (NASDAQ:AAPL), NYSE:AZO AutoZone (NYSE:AZO), Biomarin Pharmaceutical BMRN, and NYSE:BSX Boston Scientific (NYSE:BSX). All these stocks are rated overweight by Morgan Stanley.

Most U.S. investors expect that large-cap winners will continue to dominate in the fourth quarter, provided the broader market remains stable. Wilson noted similar concerns among European and U.S. clients regarding the current stage of the economic cycle and performance disparities.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2024 - Fusion Media Limited. All Rights Reserved.